Neurocrine Biosciences
NBIX----
Current ValuationThe current P/E ratio is 23.85, below the reasonable range, cheaper than 88.62% of the time in the past 3 years, and the industry ranks 43/606, the industry Median -1.90.
23.85xP/E
$164.85Stock price
$6.91Earnings per share
23.85xP/E
Stock price$164.85Earnings per share$6.91
Historical Valuation
P/E ratioTypical rangeMedian
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
013263952
The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.